共感染-话题@MedSci

#共感染#

23篇内容 | 604人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2066329, encodeId=a023206632985, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=2022年1月12日简报：欧洲超一半人口将在未来6至8周感染奥密克戎毒株；奥密克戎在美国占98%，并未出现与Delta共感染；未来所有人都可能感染奥密克戎, objectType=article, longId=293884, objectId=971d29388473, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=971d29388473, replyNumber=0, likeNumber=51, createdTime=2022-08-14, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=971d29388473, moduleTitle=2022年1月12日简报：欧洲超一半人口将在未来6至8周感染奥密克戎毒株；奥密克戎在美国占98%，并未出现与Delta共感染；未来所有人都可能感染奥密克戎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=971d29388473)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066328, encodeId=d96920663285c, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=中国女性HPV多重感染方式和共感染倾向—13.8万例妇科门诊患者的研究证据, objectType=article, longId=206076, objectId=f4e92060e659, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4e92060e659, replyNumber=0, likeNumber=35, createdTime=2021-07-15, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4e92060e659, moduleTitle=中国女性HPV多重感染方式和共感染倾向—13.8万例妇科门诊患者的研究证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4e92060e659)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066327, encodeId=31be206632eba, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=贝达喹啉治疗耐药性肺结核-HIV共感染者的相关研究及探讨, objectType=article, longId=191805, objectId=e2bd191805f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2bd191805f1, replyNumber=0, likeNumber=38, createdTime=2020-11-21, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2bd191805f1, moduleTitle=贝达喹啉治疗耐药性肺结核-HIV共感染者的相关研究及探讨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2bd191805f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066325, encodeId=d87e2066325de, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=DDS：炎症性肠病合并艰难梭菌和巨细胞病毒共感染后会导致预后不佳, objectType=article, longId=153960, objectId=f0e3153960fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0e3153960fa, replyNumber=0, likeNumber=43, createdTime=2019-07-29, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0e3153960fa, moduleTitle=DDS：炎症性肠病合并艰难梭菌和巨细胞病毒共感染后会导致预后不佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0e3153960fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066326, encodeId=5d852066326ad, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=联合用药治疗HIV和利什曼病共感染, objectType=article, longId=159086, objectId=a6391590864b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6391590864b, replyNumber=0, likeNumber=33, createdTime=2019-08-02, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6391590864b, moduleTitle=联合用药治疗HIV和利什曼病共感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6391590864b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066324, encodeId=b79b20663246f, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=J Viral Hepat：DAA治疗HBV和HCV共感染代偿期肝硬化患者时，HBV病毒再激活的风险, objectType=article, longId=145196, objectId=e18514519623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e18514519623, replyNumber=0, likeNumber=49, createdTime=2018-11-24, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e18514519623, moduleTitle=J Viral Hepat：DAA治疗HBV和HCV共感染代偿期肝硬化患者时，HBV病毒再激活的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e18514519623)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066322, encodeId=35722066322ec, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=BMC Infect Dis：瞬时弹性成像用于评估存在肝硬化的HIV/HCV共感染患者疾病预后，是无效的, objectType=article, longId=136091, objectId=50051360910e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50051360910e, replyNumber=0, likeNumber=46, createdTime=2018-11-24, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50051360910e, moduleTitle=BMC Infect Dis：瞬时弹性成像用于评估存在肝硬化的HIV/HCV共感染患者疾病预后，是无效的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50051360910e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066323, encodeId=66b72066323aa, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=Int J Tuberc Lung Dis：在HIV共感染的MDR-TB患者中，氨基糖苷类诱导的听力损失风险增加, objectType=article, longId=140553, objectId=bf84140553c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf84140553c7, replyNumber=0, likeNumber=25, createdTime=2018-08-22, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf84140553c7, moduleTitle=Int J Tuberc Lung Dis：在HIV共感染的MDR-TB患者中，氨基糖苷类诱导的听力损失风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf84140553c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066320, encodeId=8b01206632092, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=Hepatology ：DAA时代HCV/HIV共感染将不再难治, objectType=article, longId=119952, objectId=55701199525a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55701199525a, replyNumber=0, likeNumber=41, createdTime=2018-02-24, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55701199525a, moduleTitle=Hepatology ：DAA时代HCV/HIV共感染将不再难治, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55701199525a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066321, encodeId=6e1d206632162, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=Gastroenterology：在HBV-HCV共感染细胞，HBV并没有阻止IFN对HCV复制的抑制作用, objectType=article, longId=129622, objectId=32f312962272, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32f312962272, replyNumber=0, likeNumber=44, createdTime=2018-04-12, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32f312962272, moduleTitle=Gastroenterology：在HBV-HCV共感染细胞，HBV并没有阻止IFN对HCV复制的抑制作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32f312962272)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066317, encodeId=1ea9206631eaf, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=PLoS Pathog：巨噬细胞起源限制蛔虫细菌共感染的功能可塑性, objectType=article, longId=93468, objectId=490e9346840, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=490e9346840, replyNumber=0, likeNumber=33, createdTime=2017-07-06, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=490e9346840, moduleTitle=PLoS Pathog：巨噬细胞起源限制蛔虫细菌共感染的功能可塑性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=490e9346840)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066319, encodeId=dc0c20663194b, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=J Antimicrob Chemother：TB/HIV共感染患者：抗TB药物浓度与肝毒性不相关, objectType=article, longId=95521, objectId=1edc95521bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1edc95521bc, replyNumber=0, likeNumber=44, createdTime=2017-07-14, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1edc95521bc, moduleTitle=J Antimicrob Chemother：TB/HIV共感染患者：抗TB药物浓度与肝毒性不相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1edc95521bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066318, encodeId=466c2066318b9, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=The Lancet Infectious Diseases：ledipasvir与sofosbuvir联用治疗HCV-HIV共感染患者, objectType=article, longId=94431, objectId=ed25944312b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed25944312b, replyNumber=0, likeNumber=22, createdTime=2017-07-20, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed25944312b, moduleTitle=The Lancet Infectious Diseases：ledipasvir与sofosbuvir联用治疗HCV-HIV共感染患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed25944312b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066316, encodeId=bf1b206631606, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=Lancet Infect Dis：全球目前有超过230万艾滋和丙肝的共感染患者, objectType=article, longId=64666, objectId=bcbe646664c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcbe646664c, replyNumber=0, likeNumber=29, createdTime=2016-04-28, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcbe646664c, moduleTitle=Lancet Infect Dis：全球目前有超过230万艾滋和丙肝的共感染患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcbe646664c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066315, encodeId=dc25206631585, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=NEJM：Ledipasvir/Sofosbuvir治疗提高了HIV-1/HCV共感染患者的持续病毒学应答率, objectType=article, longId=53683, objectId=f61b53683e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f61b53683e0, replyNumber=0, likeNumber=40, createdTime=2016-05-03, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f61b53683e0, moduleTitle=NEJM：Ledipasvir/Sofosbuvir治疗提高了HIV-1/HCV共感染患者的持续病毒学应答率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f61b53683e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066314, encodeId=a92b2066314b7, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=Lancet HIV：Grazoprevir加Elbasvir可有效治疗HIV和HCV共感染的患者, objectType=article, longId=53180, objectId=16e6531804a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16e6531804a, replyNumber=0, likeNumber=32, createdTime=2015-09-01, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16e6531804a, moduleTitle=Lancet HIV：Grazoprevir加Elbasvir可有效治疗HIV和HCV共感染的患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16e6531804a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066312, encodeId=1316206631242, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=LANCET：Sofosbuvir联合利巴韦林可有效治疗 HCV、HIV 共感染患者, objectType=article, longId=47052, objectId=b0694e05245, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0694e05245, replyNumber=0, likeNumber=0, createdTime=2015-08-10, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0694e05245, moduleTitle=LANCET：Sofosbuvir联合利巴韦林可有效治疗 HCV、HIV 共感染患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0694e05245)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066313, encodeId=70bb2066313dd, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=JAMA：联合用药治疗HIV、HCV共感染, objectType=article, longId=48834, objectId=b1fa4883448, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1fa4883448, replyNumber=0, likeNumber=36, createdTime=2015-11-21, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1fa4883448, moduleTitle=JAMA：联合用药治疗HIV、HCV共感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1fa4883448)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066311, encodeId=f63d206631107, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=STM：cART治疗HIV/HCV共感染患者有效, objectType=article, longId=38269, objectId=100d382693c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=100d382693c, replyNumber=0, likeNumber=43, createdTime=2015-02-06, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=100d382693c, moduleTitle=STM：cART治疗HIV/HCV共感染患者有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=100d382693c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066310, encodeId=b5f8206631008, content=<a href='/topic/show?id=77be30014f4' target=_blank style='color:#2F92EE;'>#共感染#</a>, objectTitle=EASL 2014：MK-5172和MK-8742可有效治疗HCV1型和HIV共感染者, objectType=article, longId=34635, objectId=f0983463593, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0983463593, replyNumber=0, likeNumber=41, createdTime=2014-05-16, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0983463593, moduleTitle=EASL 2014：MK-5172和MK-8742可有效治疗HCV1型和HIV共感染者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0983463593)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

共感染

2020-05-29

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

2022年1月12日简报：欧洲超一半人口将在未来6至8周感染奥密克戎毒株；奥密克戎在美国占98%，并未出现与Delta共感染；未来所有人都可能感染奥密克戎

2022-08-14

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

中国女性HPV多重感染方式和共感染倾向—13.8万例妇科门诊患者的研究证据

2021-07-15

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

贝达喹啉治疗耐药性肺结核-HIV共感染者的相关研究及探讨

2020-11-21

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

DDS：炎症性肠病合并艰难梭菌和巨细胞病毒共感染后会导致预后不佳

2019-07-29

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

联合用药治疗HIV和利什曼病共感染

2019-08-02

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

J Viral Hepat：DAA治疗HBV和HCV共感染代偿期肝硬化患者时，HBV病毒再激活的风险

2018-11-24

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

BMC Infect Dis：瞬时弹性成像用于评估存在肝硬化的HIV/HCV共感染患者疾病预后，是无效的

2018-11-24

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

Int J Tuberc Lung Dis：在HIV共感染的MDR-TB患者中，氨基糖苷类诱导的听力损失风险增加

2018-08-22

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

Hepatology ：DAA时代HCV/HIV共感染将不再难治

2018-02-24

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

Gastroenterology：在HBV-HCV共感染细胞，HBV并没有阻止IFN对HCV复制的抑制作用

2018-04-12

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

PLoS Pathog：巨噬细胞起源限制蛔虫细菌共感染的功能可塑性

2017-07-06

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

J Antimicrob Chemother：TB/HIV共感染患者：抗TB药物浓度与肝毒性不相关

2017-07-14

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

The Lancet Infectious Diseases：ledipasvir与sofosbuvir联用治疗HCV-HIV共感染患者

2017-07-20

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

Lancet Infect Dis：全球目前有超过230万艾滋和丙肝的共感染患者

2016-04-28

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

NEJM：Ledipasvir/Sofosbuvir治疗提高了HIV-1/HCV共感染患者的持续病毒学应答率

2016-05-03

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

Lancet HIV：Grazoprevir加Elbasvir可有效治疗HIV和HCV共感染的患者

2015-09-01

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

LANCET：Sofosbuvir联合利巴韦林可有效治疗 HCV、HIV 共感染患者

2015-08-10

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

JAMA：联合用药治疗HIV、HCV共感染

2015-11-21

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

STM：cART治疗HIV/HCV共感染患者有效

2015-02-06

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#共感染#

EASL 2014：MK-5172和MK-8742可有效治疗HCV1型和HIV共感染者

2014-05-16

科室
- - 订阅+
  - 更多科室
工具
服务